Cangrelor Neonatal PK/PD and Safety Study
Study Identifier:
MDCO-CAN-15-01
ClinicalTrials.gov Identifier:
EudraCT Identifier:
Study Contact Information:
N/A
Study Complete
Study Details
Medical Condition
- Thrombosis
Study Drug
- Drug: Cangrelor
Date
Jan 2017 - Aug 2019
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 1 Day - 28 Days
Requirements Information
Healthy Volunteers
No
Protocol Summary
The purpose of this study is to assess the PK/PD and safety profile of cangrelor in neonatal participants at risk of thrombosis.
Study Locations
Location
Status
Location
Columbia University Medical Center
New York, New York, United States, 10032
Status
N/A
Location
UPMC Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15224
Status
N/A